Aperture Venture Partners, a New York-based venture fund established in 2002, specializes in investing in the Seed to Series D stages. With a focus on BioTech, Healthcare, Medical Device, and Software sectors, the fund has invested in 53 companies and successfully exited 23. Tony Natale is a key partner at Aperture Venture Partners, overseeing investments in companies like Endotronix and Bardy Diagnostics. For more information, visit their website at www.aperturevp.com.